Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 51–100 of 442 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01295944	Carboplatin and Bevacizumab for Recurrent Ependymoma	completed	Phase 2	35	National Cancer Institute (NCI)NIH	1	Aug 5, 2025	clinicaltrials
NCT03137888	Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma	completed	Phase 2	30	Emory UniversityOTHER	1	Aug 3, 2025	clinicaltrials
NCT02986178